Microbial Resource Management Technologies: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Microbial Resource Management Technologies
Largest movements
- Receivables within one year -€14.9m
down €14.9m (-99.9%), from €14.9m to €18,279
of which Other amounts receivable: -€14.9m
- Other debts -€14.8m
down €14.8m (-98.4%), from €15.0m to €240,386
- Gross operating margin -€5.9m
down €5.9m (-98.9%), from €5.9m to €65,628
- Financial income -€115,539
down €115,539 (-99.9%), from €115,646 to €107
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €29,499,671 | €14,589,655 | -€14.9m | -50.5% |
| Fixed assets | 21/28 | €14,517,068 | €14,450,421 | -€66,647 | -0.5% |
| Tangible fixed assets | 22/27 | €132,398 | €65,751 | -€66,647 | -50.3% |
| Plant, machinery and equipment | 23 | €99,864 | €46,501 | -€53,363 | -53.4% |
| Furniture and vehicles | 24 | €23,147 | €11,542 | -€11,605 | -50.1% |
| Other tangible fixed assets | 26 | €9,386 | €7,707 | -€1,679 | -17.9% |
| Financial fixed assets | 28 | €14,384,670 | €14,384,670 | = | 0.0% |
| Current assets | 29/58 | €14,982,603 | €139,233 | -€14.8m | -99.1% |
| Amounts receivable within one year | 40/41 | €14,880,383 | €18,279 | -€14.9m | -99.9% |
| Trade receivables | 40 | €0 | - | = | |
| Other amounts receivable | 41 | €14,880,383 | €18,279 | -€14.9m | -99.9% |
| Cash at bank and in hand | 54/58 | €2,641 | €3,039 | +€398 | +15.1% |
| Deferred charges and accrued income | 490/1 | €99,579 | €117,915 | +€18,336 | +18.4% |
| Total equity and liabilities | 10/49 | €29,499,671 | €14,589,655 | -€14.9m | -50.5% |
| Equity | 10/15 | €12,432,540 | €12,332,804 | -€99,737 | -0.8% |
| Contributions | 10/11 | €6,982,172 | €6,982,172 | = | 0.0% |
| Capital | 10 | €6,982,172 | €6,982,172 | = | 0.0% |
| Issued capital | 100 | €6,982,172 | €6,982,172 | = | 0.0% |
| Reserves | 13 | €272,545 | €272,545 | = | 0.0% |
| Non-distributable reserves | 130/1 | €272,545 | €272,545 | = | 0.0% |
| Legal reserve | 130 | €272,545 | €272,545 | = | 0.0% |
| Profit (loss) carried forward | 14 | €5,177,824 | €5,078,087 | -€99,737 | -1.9% |
| Amounts payable | 17/49 | €17,067,131 | €2,256,851 | -€14.8m | -86.8% |
| Amounts payable after more than one year | 17 | €1,579,203 | €1,573,870 | -€5,333 | -0.3% |
| Financial debts | 170/4 | €1,579,203 | €1,573,870 | -€5,333 | -0.3% |
| Amounts payable within one year | 42/48 | €15,309,691 | €433,896 | -€14.9m | -97.2% |
| Current portion of amounts payable after more than one year | 42 | €26,885 | €5,333 | -€21,553 | -80.2% |
| Trade debts | 44 | €247,393 | €188,178 | -€59,215 | -23.9% |
| Suppliers | 440/4 | €247,393 | €188,178 | -€59,215 | -23.9% |
| Taxes, remuneration and social security | 45 | €780 | €0 | -€780 | -100.0% |
| Taxes | 450/3 | €780 | €0 | -€780 | -100.0% |
| Other amounts payable | 47/48 | €15,034,633 | €240,386 | -€14.8m | -98.4% |
| Accrued charges and deferred income | 492/3 | €178,237 | €249,085 | +€70,847 | +39.7% |
| Non-recurring operating income | 76A | €5,893,800 | €0 | -€5.9m | -100.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €99,914 | €66,647 | -€33,267 | -33.3% |
| Other operating charges | 640/8 | €1,154 | €1,189 | +€35 | +3.0% |
| Non-recurring operating charges | 66A | €7,023 | €0 | -€7,023 | -100.0% |
| Gross operating margin | 9900 | €5,917,587 | €65,628 | -€5.9m | -98.9% |
| Operating profit (loss) | 9901 | €5,809,496 | -€2,208 | -€5.8m | |
| Financial income | 75/76B | €115,646 | €107 | -€115,539 | -99.9% |
| Recurring financial income | 75 | €115,646 | €107 | -€115,539 | -99.9% |
| Financial charges | 65/66B | €108,187 | €97,636 | -€10,551 | -9.8% |
| Recurring financial charges | 65 | €108,187 | €97,636 | -€10,551 | -9.8% |
| Profit (loss) for the period before taxes | 9903 | €5,816,955 | -€99,737 | -€5.9m | |
| Profit (loss) for the period | 9904 | €5,816,955 | -€99,737 | -€5.9m | |
| Profit (loss) for the period to be appropriated | 9905 | €5,816,955 | -€99,737 | -€5.9m |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.